You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 9,775,849


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 9,775,849
Title:Implants and methods for treating inflammation-mediated conditions of the eye
Abstract: Methods for treating inflammation-mediated conditions of the eye are described, comprising: implanting into the vitreous of the eye of an individual a bioerodible implant comprising a steroidal anti-inflammatory agent and a bioerodible polymer, wherein the implant delivers the agent to the vitreous in an amount sufficient to reach a concentration equivalent to at least about 0.05 .mu.g/ml dexamethasone within about 48 hours and maintains a concentration equivalent to at least about 0.03 .mu.g/ml dexamethasone for at least about three weeks.
Inventor(s): Wong; Vernon G. (Menlo Park, CA), Hu; Mae W. L. (Los Altos Hills, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:14/691,079
Patent Claim Types:
see list of patent claims
Use; Device;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 9,775,849: A Comprehensive Analysis

Introduction

Patents are a cornerstone of innovation, providing inventors and companies with the exclusive rights to their inventions. The United States Patent 9,775,849, like any other patent, is subject to a complex set of rules and regulations that define its scope, claims, and overall place within the patent landscape. This article delves into the key aspects of this patent, exploring its claims, the legal framework governing it, and the broader implications within the U.S. patent system.

Patent Basics: Understanding the U.S. Patent System

Before diving into the specifics of Patent 9,775,849, it is essential to understand the basic structure of the U.S. patent system. The Patent Act of 1952, codified in Title 35 of the U.S. Code, outlines the general mechanics of patent administration. The United States Patent and Trademark Office (USPTO) is responsible for issuing patents on behalf of the government[4].

Types of Patents

The USPTO grants three main types of patents: utility patents, design patents, and plant patents. Utility patents, which are the most common, are granted for new and useful processes, machines, articles of manufacture, or compositions of matter, or any new and useful improvement thereof[4].

Patent Claims: The Heart of a Patent

Patent claims define the scope of the invention and are crucial for determining the patent's validity and enforceability. The Patent Claims Research Dataset by the USPTO provides detailed information on claims from U.S. patents, including claim-level statistics and document-level statistics. This dataset helps in understanding the complexity and scope of patent claims[3].

The Importance of Inventorship

Correctly determining who should be listed as an inventor is vital. U.S. patent law requires that only the "true and only" inventors be listed on a patent application. Errors in inventorship, especially those involving deceptive intent, can render a patent invalid and unenforceable[2].

Obviousness-Type Double Patenting (ODP)

Obviousness-type double patenting is a critical concept that can affect the validity of patent claims. This issue arises when multiple patents from the same family claim the same invention or obvious variations thereof. The case of In re Cellect highlights the complexities of ODP, where multiple patents were invalidated due to their obviousness over a prior-expiring reference patent[1].

Patent Term Adjustment (PTA) and Patent Term Extension (PTE)

Patent Term Adjustment (PTA) and Patent Term Extension (PTE) are mechanisms that can extend the life of a patent. However, these extensions must be carefully considered in the context of ODP. The In re Cellect case illustrates how PTA can affect the expiration dates of patents and their validity under ODP analysis[1].

The Specifics of United States Patent 9,775,849

Patent Title and Abstract

To analyze the scope and claims of Patent 9,775,849, one must start with the patent title and abstract. These sections provide a general overview of the invention, including its purpose, functionality, and key features.

Claims

The claims section is the most critical part of the patent, as it defines the legal boundaries of the invention. Each claim must be carefully crafted to ensure it is novel, non-obvious, and useful. The claims can be independent or dependent, with dependent claims building upon the independent ones.

Description and Drawings

The description and drawings sections provide detailed explanations and visual representations of the invention. These are essential for understanding how the invention works and its various components.

Prior Art and Background

Understanding the prior art and background of the invention helps in assessing its novelty and non-obviousness. This section often includes references to earlier patents and publications that are relevant to the current invention.

Legal Framework and Enforcement

Patent Litigation

Patent litigation can arise from disputes over the validity or infringement of patent claims. The U.S. court system, particularly the Court of Appeals for the Federal Circuit, plays a crucial role in resolving these disputes[2].

Small Claims Patent Court

There has been ongoing discussion about the feasibility of a small claims patent court to handle lower-stakes patent disputes more efficiently. The Administrative Conference of the United States (ACUS) has conducted studies on this topic, engaging with various stakeholders to explore the legal, policy, and practical considerations[5].

Economic and Innovation Impact

Patent Scope and Innovation

The scope of a patent, as defined by its claims, can significantly impact innovation. Broader claims may stifle innovation by limiting the space for other inventors, while narrower claims may encourage more innovation by allowing for more variations[3].

Productivity and Economic Growth

The U.S. patent system is correlated with productivity growth and economic development. Patents provide a legal framework that incentivizes innovation, leading to technological advancements and economic growth[4].

Case Studies and Examples

In re Cellect

The In re Cellect case highlights the complexities of ODP and the importance of careful patent prosecution. This case involved multiple patents from the same family, each of which was subject to ODP analysis. The outcome underscored the need for meticulous management of patent families to avoid invalidation[1].

Frank’s Casing Crew v. PMR Technologies

This case emphasizes the importance of correct inventorship. The patent in question was invalidated due to deceptive intent in naming the inventors, illustrating the severe consequences of errors in inventorship[2].

Key Takeaways

  • Patent Claims: The claims section is crucial for defining the scope and validity of a patent.
  • Inventorship: Correctly identifying the true and only inventors is essential to avoid patent invalidation.
  • ODP: Obviousness-type double patenting can invalidate patent claims if not managed properly.
  • PTA and PTE: Patent Term Adjustment and Patent Term Extension can affect the expiration dates and validity of patents.
  • Legal Framework: Understanding the legal framework, including litigation and potential small claims courts, is vital for patent enforcement.

FAQs

What is the significance of the claims section in a patent?

The claims section defines the legal boundaries of the invention, determining what is protected and what is not.

Why is correct inventorship important?

Correct inventorship is crucial because errors, especially those involving deceptive intent, can render a patent invalid and unenforceable.

What is obviousness-type double patenting (ODP)?

ODP occurs when multiple patents from the same family claim the same invention or obvious variations thereof, potentially invalidating the claims.

How do Patent Term Adjustment (PTA) and Patent Term Extension (PTE) affect patents?

PTA and PTE can extend the life of a patent, but they must be carefully considered in the context of ODP to avoid invalidation.

What is the role of the Court of Appeals for the Federal Circuit in patent disputes?

The Court of Appeals for the Federal Circuit is the appellate court that hears appeals for patent cases originating in federal district courts, playing a crucial role in resolving patent disputes.

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1].
  2. Determining Inventorship for US Patent Applications - Oregon State University[2].
  3. Patent Claims Research Dataset - USPTO[3].
  4. Patents and Innovation Policy - Congressional Research Service[4].
  5. U.S. Patent Small Claims Court - Administrative Conference of the United States[5].

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,775,849

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,775,849

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 029567 ⤷  Subscribe
Austria 339185 ⤷  Subscribe
Australia 2001273166 ⤷  Subscribe
Australia 2005246995 ⤷  Subscribe
Australia 7316601 ⤷  Subscribe
Brazil 0112361 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.